Cargando…
PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429208/ http://dx.doi.org/10.1097/01.HS9.0000850916.45282.84 |
| _version_ | 1784779366892306432 |
|---|---|
| author | Ionova, T. Vinogradova, O. Kochkareva, Y. Ado, E. Kaplanov, K. Shirokova, M. Shelekhova, T. Levanov, A. Kopylova, A. Li, O. Mitina, T. Rukavitsyn, O. Simashova, P. Anchukova, L. Babich, E. Dasheeva, D. Demchenkova, M. Dubov, S. Esenina, T. Ivanova, L. Kravchuk, T. Rimashevskaya, E. Saraeva, N. Savinova, M. Volkova, S. Porfirieva, N. Nikitina, T. |
| author_facet | Ionova, T. Vinogradova, O. Kochkareva, Y. Ado, E. Kaplanov, K. Shirokova, M. Shelekhova, T. Levanov, A. Kopylova, A. Li, O. Mitina, T. Rukavitsyn, O. Simashova, P. Anchukova, L. Babich, E. Dasheeva, D. Demchenkova, M. Dubov, S. Esenina, T. Ivanova, L. Kravchuk, T. Rimashevskaya, E. Saraeva, N. Savinova, M. Volkova, S. Porfirieva, N. Nikitina, T. |
| author_sort | Ionova, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429208 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292082022-08-31 PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY Ionova, T. Vinogradova, O. Kochkareva, Y. Ado, E. Kaplanov, K. Shirokova, M. Shelekhova, T. Levanov, A. Kopylova, A. Li, O. Mitina, T. Rukavitsyn, O. Simashova, P. Anchukova, L. Babich, E. Dasheeva, D. Demchenkova, M. Dubov, S. Esenina, T. Ivanova, L. Kravchuk, T. Rimashevskaya, E. Saraeva, N. Savinova, M. Volkova, S. Porfirieva, N. Nikitina, T. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429208/ http://dx.doi.org/10.1097/01.HS9.0000850916.45282.84 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Ionova, T. Vinogradova, O. Kochkareva, Y. Ado, E. Kaplanov, K. Shirokova, M. Shelekhova, T. Levanov, A. Kopylova, A. Li, O. Mitina, T. Rukavitsyn, O. Simashova, P. Anchukova, L. Babich, E. Dasheeva, D. Demchenkova, M. Dubov, S. Esenina, T. Ivanova, L. Kravchuk, T. Rimashevskaya, E. Saraeva, N. Savinova, M. Volkova, S. Porfirieva, N. Nikitina, T. PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY |
| title | PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY |
| title_full | PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY |
| title_fullStr | PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY |
| title_full_unstemmed | PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY |
| title_short | PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY |
| title_sort | pb2021: quality of life and clinical outcomes in patients with relapsed/refractory multiple myeloma (rrmm) treated with ixazomib-lenalidomide-dexamethasone (ird): results of a real-world evidence study |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429208/ http://dx.doi.org/10.1097/01.HS9.0000850916.45282.84 |
| work_keys_str_mv | AT ionovat pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT vinogradovao pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT kochkarevay pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT adoe pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT kaplanovk pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT shirokovam pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT shelekhovat pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT levanova pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT kopylovaa pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT lio pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT mitinat pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT rukavitsyno pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT simashovap pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT anchukoval pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT babiche pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT dasheevad pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT demchenkovam pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT dubovs pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT eseninat pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT ivanoval pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT kravchukt pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT rimashevskayae pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT saraevan pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT savinovam pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT volkovas pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT porfirievan pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy AT nikitinat pb2021qualityoflifeandclinicaloutcomesinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithixazomiblenalidomidedexamethasoneirdresultsofarealworldevidencestudy |